Dixon Hubard Feinour & Brown’s Elevance Health ELV Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$5.64M	Sell	11,681 -477	-4%	-$236K	0.67%	51
2022 Q1	$5.97M	Buy	12,158 +250	+2%	+$114K	0.6%	47
2021 Q4	$5.52M	Buy	11,908 +10,737	+917%	+$4.52M	0.53%	57
2021 Q3	$437K	Sell	1,171 -121	-9%	-$46K	0.09%	130
2021 Q2	$493K	Sell	1,292 -1,625	-56%	-$621K	0.1%	120
2021 Q1	$900K	Buy	2,917 +1,292	+80%	+$415K	0.11%	118
2020 Q4	$436K	Hold	1,625	–	–	0.11%	110
2020 Q3	$436K	Hold	1,625	–	–	0.11%	110
2020 Q2	$431K	Buy	1,625 +3	+0.2%	+$800	0.11%	110
2020 Q1	$368K	Sell	1,622 -311	-16%	-$84.8K	0.12%	107
2019 Q4	$584K	Hold	1,933	–	–	0.15%	100
2019 Q3	$464K	Sell	1,933 -8	-0.4%	-$2.19K	0.13%	112
2019 Q2	$548K	Buy	1,941 +8	+0.4%	+$2.19K	0.16%	104
2019 Q1	$555K	Buy	1,933 +11	+0.6%	+$3.18K	0.17%	101
2018 Q4	$505K	Sell	1,922 -4	-0.2%	-$1.1K	0.19%	101
2018 Q3	$528K	Hold	1,926	–	–	0.15%	110
2018 Q2	$458K	Hold	1,926	–	–	0.13%	111
2018 Q1	$423K	Buy	1,926 +210	+12%	+$49.3K	0.12%	118
2017 Q4	$386K	Hold	1,716	–	–	0.1%	126
2017 Q3	$326K	Hold	1,716	–	–	0.09%	140
2017 Q2	$323K	Hold	1,716	–	–	0.09%	139
2017 Q1	$284K	Hold	1,716	–	–	0.08%	142
2016 Q4	$247K	Hold	1,716	–	–	0.08%	146
2016 Q3	$215K	Hold	1,716	–	–	0.07%	162
2016 Q2	$225K	Hold	1,716	–	–	0.07%	153
2016 Q1	$242K	Hold	1,716	–	–	0.08%	148
2015 Q4	$239K	Buy	1,716 +75	+5%	+$10.3K	0.08%	144
2015 Q3	$230K	Hold	1,641	–	–	0.08%	139
2015 Q2	$269K	Hold	1,641	–	–	0.08%	148
2015 Q1	$253K	Buy	+1,641	New	+$234K	0.07%	170

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Dixon Hubard Feinour & Brown's ELV Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Elevance Health (ELV) stake by 3.9% in Q2 2022, selling an estimated $236K and leaving 11,681 shares worth $5.64M. The position accounts for 0.67% of the portfolio, ranked #51.

Dixon Hubard Feinour & Brown first reported a position in ELV in Q1 2015 and has held it in 30 quarters since. The position peaked at $5.97M in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Dixon Hubard Feinour & Brown held 11,681 shares of Elevance Health worth $5.64M as of Q2 2022.
Dixon Hubard Feinour & Brown sold 477 Elevance Health shares in Q2 2022, an estimated $236K.
Elevance Health made up 0.67% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #51 holding.
Dixon Hubard Feinour & Brown first reported a position in Elevance Health in Q1 2015 and has held it in 30 quarters since.
Dixon Hubard Feinour & Brown's Elevance Health position peaked at $5.97M in Q1 2022.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.